Team Approach Improves Retinoblastoma Management

Using multidisciplinary care, genetic analysis done in 63 percent of retinoblastoma probands

WEDNESDAY, Nov. 16 (HealthDay News) -- Genetic testing can be integrated into the management plan of retinoblastoma (RB) using a multidisciplinary approach, according to a study published in the November issue of the Archives of Ophthalmology.

Shweta U. Dhar, M.D., from Baylor College of Medicine in Houston, and colleagues investigated the role of genetic testing in management of patients with RB, using data from an eight year period. A cohort comprising 81 children diagnosed with RB, including 34 with bilateral and 47 with unilateral RB, and nine children with a positive family history of RB, was evaluated by a multidisciplinary team, including pediatric oncologists, an ophthalmologist, an ophthalmic pathologist, a geneticist, and genetic counselors.

The investigators found that genetic testing was accomplished in 63 percent of 81 patients, with an equivalent rate of testing in bilateral and unilateral cases. Peripheral blood samples identified an RB1 mutation in five of 30 patients with unilateral disease. The occurrence of sporadic RB was confirmed through mutation analysis in seven of 30 patients. Genetic testing revealed six positive and 42 negative individuals for the familial mutation among 48 at-risk family members belonging to 21 families.

"Our study emphasizes that genetics can be incorporated into the management plan of all retinoblastoma patients using a team approach to ensure timely evaluations and appropriate counseling," the authors write.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2011 HealthDay. All rights reserved.

Powered by

jQuery UI Accordion - Default functionality

For life-long learning and continuing professional development, come to Lippincott's NursingCenter.

Nursing Jobs Plus
Featured Jobs
Recommended CE Articles Recommended Nursing Articles

What internal motivators drive RNs to pursue a BSN?
Nursing2014 , October 2014
Free access will expire on November 24, 2014.


Breast Cancer Risk Assessment in Primary Care
MCN, The American Journal of Maternal/Child Nursing, September/October 2014
Free access will expire on November 10, 2014.


Nurses spurring innovation
Nursing Management, October 2014
Free access will expire on November 10, 2014.


More Recommended Articles

Subscribe to Recommended Articles

Evidence Based Practice Skin Care Network NursingCenter Quick Links What’s Trending Events